Back to Authors

Owen, Barbara AL

Mayo Clinic

Department of Molecular Pharmacology and Experimental Therapeutics,

Citations 1

Trimolecular Complexes of λ Light Chain Dimers in Serum of a Patient with Multiple Myeloma
Abraham, Roshini S. , Charlesworth, M. Cristine , Owen, Barbara, Benson, Linda M., Katzmann, Jerry A., Reeder, Craig B. , Kyle, Robert A. , Charlesworth, M. Cristine , Owen, Barbara AL

Clinical Chemistry | January 24, 2020 | Volume: 48 | Issue: 10 | Pages: 1805-1811

10.1093/clinchem/48.10.1805 Get It

AbstractBackground: Patients with multiple myeloma often have Bence Jones proteins composed of free monoclonal light chains of the κ or λ type in their urine. Usually, these light chains exist as monomeric or dimeric forms, but rarely, larger molecules, such as tetramers, have been reported in the serum.Methods and Results: We report the presence of trimeric complexes of λ light chain dimers in a patient who was diagnosed with a free λ light chain multiple myeloma 2 years earlier and subsequently underwent a stem cell transplant. Recently, the patient presented with a large serum M-spike (23 g/L) by protein electrophoresis. The spike consisted of monoclonal λ light chains without a heavy chain. The urine contained only 8 mg of λ light chain in a 24-h specimen. Quantitative analysis of the serum and urinary free light chains (FLCs) indicated the probability of larger aggregates of FLCs. Size-exclusion chromatography, electrophoresis, analytical ultracentrifugation, and mass spectrometric studies of the serum revealed almost exclusively the presence of trimolecular aggregates of λ light chain dimers without other multimeric species.Conclusion: Monoclonal λ light chains may present as hexameric aggregates that cannot be cleared by renal excretion.